Anbio Biotechnology (NASDAQ:NNNN) Trading Up 11.3% – Still a Buy?

Anbio Biotechnology (NASDAQ:NNNN) shares rose 11.3% during mid-day trading on Friday . The stock traded as high as $34.96 and last traded at $33.6550. Approximately 16,692 shares were traded during mid-day trading, a decline of 63% from the average daily volume of 44,863 shares. The stock had previously closed at $30.25.

Wall Street Analyst Weigh In

Separately, Weiss Ratings upgraded shares of Anbio Biotechnology from a “sell (d+)” rating to a “hold (c-)” rating in a report on Thursday, May 14th. One research analyst has rated the stock with a Hold rating, According to data from MarketBeat, Anbio Biotechnology has a consensus rating of “Hold”.

Anbio Biotechnology Trading Up 15.4%

The stock’s fifty day moving average price is $26.01.

Anbio Biotechnology (NASDAQ:NNNN) last issued its quarterly earnings results on Tuesday, April 7th. The company reported $0.03 earnings per share (EPS) for the quarter.

About Anbio Biotechnology

Anbio Biotechnology is dedicated to the advancement of medical technology and the provision of in vitro diagnostics (IVD) products. Our unwavering commitment lies in transforming the diagnostics landscape on a global scale, fostering a paradigm shift towards personalized and decentralized diagnostic solutions. By doing so, we aim to significantly enhance patient prognosis and contribute to the betterment of healthcare worldwide. At Anbio Biotechnology, our extensive portfolio comprises an array of IVD products designed to cater to diverse diagnostic needs.